Abstract
Dexamethasone implant (Ozurdex™) is a relatively safe medication with few adverse events can happen. We demonstrate clinical course and images of a rare case of fractured intravitreal Ozurdex™ implant that observed immediately following injection and its final outcome.
Keywords
Publication details
- DOI
- 10.4103/ojo.ojo_31_21
- Journal
- Oman Journal of Ophthalmology, 14(3), 201-202
- Publisher
- Medknow Publications
- Open access
- Gold open access
Cite this article
APA 7
Aljohani, S. M., Al-Shehri, A. M., & Al-Rubaie, K. R. (2021). Fractured dexamethasone implant (OZURDEX®) following intravitreal injection. Oman Journal of Ophthalmology, 14(3), 201-202. https://doi.org/10.4103/ojo.ojo_31_21
MLA 9
Aljohani, Saud M, et al. "Fractured dexamethasone implant (OZURDEX®) following intravitreal injection." Oman Journal of Ophthalmology, vol. 14, no. 3, 2021, pp. 201-202. https://doi.org/10.4103/ojo.ojo_31_21.
Chicago (author–date)
Aljohani, Saud M, Abdulaziz M Al-Shehri, and Khalid R Al-Rubaie. 2021. "Fractured dexamethasone implant (OZURDEX®) following intravitreal injection." Oman Journal of Ophthalmology 14 (3): 201-202. https://doi.org/10.4103/ojo.ojo_31_21.
Harvard
Aljohani, S. M., Al-Shehri, A. M. and Al-Rubaie, K. R. (2021) 'Fractured dexamethasone implant (OZURDEX®) following intravitreal injection', Oman Journal of Ophthalmology, 14(3), pp. 201-202. doi:10.4103/ojo.ojo_31_21.
Vancouver
Aljohani SM, Al-Shehri AM, Al-Rubaie KR. Fractured dexamethasone implant (OZURDEX®) following intravitreal injection. Oman Journal of Ophthalmology. 2021;14(3):201-202. doi:10.4103/ojo.ojo_31_21
IEEE
S. M. Aljohani, A. M. Al-Shehri, and K. R. Al-Rubaie, "Fractured dexamethasone implant (OZURDEX®) following intravitreal injection," Oman Journal of Ophthalmology, vol. 14, no. 3, pp. 201-202, 2021, doi: 10.4103/ojo.ojo_31_21.